Qube Research & Technologies LTD Gilead Sciences, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4,828,551 shares of GILD stock, worth $599 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

4,828,551

Previous 4,758,575 1.47%

Holding current value

$599 Million

Previous $528 Million 1.59%

% of portfolio

0.59%

Previous 0.56%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$108.22 - $120.47 $7.57 Million - $8.43 Million	69,976 Added 1.47%	4,828,551 $536 Million
Q2 2025 Aug 14, 2025	BUY	$96.91 - $113.0 $233 Million - $271 Million	2,401,289 Added 101.87%	4,758,575 $528 Million
Q1 2025 May 15, 2025	BUY	$89.14 - $117.41 $210 Million - $277 Million	2,357,286 New	2,357,286 $264 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $44.4 Million - $51.2 Million	-703,042 Reduced 31.77%	1,509,613 $104 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $108 Million - $132 Million	1,508,607 Added 214.28%	2,212,655 $162 Million

Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $32.7 Million - $37.1 Million	-446,276 Reduced 38.8%	704,048 $57 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $31.7 Million - $34.6 Million	428,583 Added 59.38%	1,150,324 $86.2 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $38.4 Million - $43.8 Million	505,201 Added 233.31%	721,741 $55.6 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $16.7 Million - $19.1 Million	216,540 New	216,540 $18 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $17.8 Million - $20.4 Million	299,321 Added 44.55%	971,154 $59.9 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $5.72 Million - $6.45 Million	99,164 Added 17.32%	671,833 $41.5 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $13.9 Million - $17.4 Million	-240,073 Reduced 29.54%	572,669 $34 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $49.4 Million - $56.1 Million	761,375 Added 1482.23%	812,742 $59 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $246,459 - $265,902	-3,641 Reduced 6.62%	51,367 $3.59 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $2.46 Million - $2.69 Million	-38,801 Reduced 41.36%	55,008 $3.79 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $4.08 Million - $4.66 Million	68,042 Added 264.07%	93,809 $6.06 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $22.5 Million - $25.6 Million	-396,671 Reduced 93.9%	25,767 $1.5 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $26.2 Million - $33 Million	422,438 New	422,438 $26.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $3.78 Million - $4.39 Million	-52,287 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $517,261 - $662,536	8,259 Added 18.76%	52,287 $3.91 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $1.67 Million - $1.84 Million	27,122 Added 160.43%	44,028 $2.86 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $920,084 - $1.02 Million	-14,719 Reduced 46.54%	16,906 $1.07 Million
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $71,459 - $80,133	-1,155 Reduced 3.52%	31,625 $2.14 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.05 Million - $2.3 Million	32,780 New	32,780 $2.13 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $2.22 Million - $2.89 Million	-36,604 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.98 Million - $2.2 Million	27,826 Added 317.0%	36,604 $2.83 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $259 - $302	-4 Reduced 0.05%	8,778 $622,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $639,680 - $779,841	8,782 New	8,782 $662,000

Others Institutions Holding GILD

# of Institutions

2,367

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Gilead Sciences, Inc. Transaction History